Table 2.
Available medicines in treatment protocols
| Medicine | Availability (%) |
|---|---|
| ALL protocol | |
| Prednisolone | 60 |
| Vincristine | 60 |
| Daunorubicin | 20 |
| Asparaginase | 20 |
| Cytarabine | 20 |
| Methotrexate | 80 |
| Cyclophosphamide | 40 |
| Mercaptopurine | 20 |
| Dexamethasone | 80 |
| Doxorubicin | 40 |
| Thioguanine | 20 |
| AML protocol | |
| Etoposide | 20 |
| Daunorubicin | 20 |
| Amsacrine | 0 |
| Mitoxantrone | 20 |
| Asparaginase | 20 |
| Cytarabine | 20 |
| LMB protocol | |
| Prednisolone | 60 |
| Cyclophosphamide | 40 |
| Vincristine | 60 |
| Folinic acid | 20 |
| Hydrocortisone sodium succinate | 60 |
| Cytarabine | 20 |
| Methotrexate | 80 |
| Doxorubicin | 40 |
| Brain tumor protocol | |
| Procarbazine | 20 |
| Prednisolone | 60 |
| Cisplatin | 80 |
| Temozolomide | 40 |
| Cyclophosphamide | 40 |
| Vincristine | 60 |
| Etoposide | 20 |
| Wilms tumor protocol | |
| Dactinomycin | 20 |
| Cyclophosphamide | 40 |
| Vincristine | 60 |
| Etoposide | 20 |
| Doxorubicin | 40 |